Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
I performed the exhaustive protein tyrosine kinase assay of 3 CTCL cell lines (Hut78, HH and MJ) with 3 HDACi (romidepsin, vorinostat and belinostat) by Pamchip and found that all tested HDACi upregulated phosphorylation activity of MAPK1/ERK2 in Hut78. Furthermore, inhibitors of MEK, an upstream kinase of MAPK1, significantly enhanced the anti-proliferative effect of HDACi in Hut78.
|